1.
Radiol Clin North Am
; 51(5): 781-98, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24010906
RESUMO
Although positron emission tomography (PET) imaging may not be used in the diagnosis of breast cancer, the use of PET/computed tomography is imperative in all aspects of breast cancer staging, treatment, and follow-up. PET will continue to be relevant in personalized medicine because accurate tumor status will be even more critical during and after the transition from a generic metabolic agent to receptor imaging. Positron emission mammography is an imaging proposition that may have benefits in lower doses, but its use is limited without new radiopharmaceuticals.
Assuntos
Neoplasias da Mama/diagnóstico por imagem , Imagem Multimodal , Neoplasias da Mama/patologia , Feminino , Fluordesoxiglucose F18 , Humanos , Metástase Linfática , Metástase Neoplásica/diagnóstico por imagem , Metástase Neoplásica/patologia , Estadiamento de Neoplasias , Medicina de Precisão , Prognóstico , Cintilografia , Compostos Radiofarmacêuticos , Sensibilidade e Especificidade
2.
J Am Coll Radiol
; 12(2): 206-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25240487